Last updated: 3 months ago
Agios Pharmaceuticals Q4 2024 Financial Report: Growth Amid Risks
Explore Agios Pharmaceuticals' Q4 2024 financial performance, highlighting revenue growth, cash position, and risks. Key insights on PYRUKYND® and market outlook included.